Daniel Geleta .

Dr. Daniel Geleta .


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2018 in Sleep Disorders
Verified
Journal Article
Open access
PDF file
HBHiwot Berhanu
Hiwot Berhanu
AMAndualem Mossie
Andualem Mossie
STSamuel Tadesse
Samuel Tadesse
DGDaniel Geleta
Daniel Geleta
Background. An estimated 150 million people worldwide and nearly 17% of the populations in the developing nations are currently suffering from sleep problems. The aim of the present study was to determine the prevalence and associated factors of sleep quality among adults in Ethiopia.Method. A cross-sectional study was conducted on 422 randomly selected adults using validated and pretested Pittsburgh Sleep Quality Index. Data were entered into EpiData and analyzed using SPSS version 20 considering bivariable (Pvalue < 0.25) and multivariable(P<0.05)logistic regression procedures at 95% confidence interval.Result. The overall prevalence of poor sleep quality (PSQI score > 5) was 65.4% with higher proportion among males (79 (63.0%)) and age group of 40–49 years (174 (28.6%)). A multivariable logistic regression analysis indicated that age category of 40–49 years (AOR = 2 [95% CI (1.1, 3.6)])(P=0.03), monthly income ≤ 1000 ETB (AOR = 2.2 [95% CI (14, 3.5)])(P=0.01), current khat chewing (AOR = 1.8 [95% CI (1.1, 3.1)])(P=0.03), daily khat chewing (AOR = 3.4 [95% CI (1.2, 11.1)])(P=0.04), and obesity (AOR = 1.2 [95% CI (1.3, 2.5)])(P=0.03)were identified as risk factors of poor sleep quality.Conclusion. The current study is informative for government to work on poverty reduction, create awareness for weight reduction, and develop legislation for khat control to prevent poor sleep quality.

16 September 2024 in PLOS ONE
Verified
Journal Article
Open access
DGDaniel Geleta
Daniel Geleta
GAGemeda Abebe
Gemeda Abebe
TTTsion Tilahun
Tsion Tilahun
DGDidimos Gezahegn
Didimos Gezahegn
NWNetsanet Workneh
Netsanet Workneh
GBGetenet Beyene
Getenet Beyene
Background: Epidemiological profiles and the rundown crisis of antimicrobial resistance from bacterial isolates in neonatal sepsis compel regular surveillance to enhance data-driven decision-making. Accordingly, this study aimed to assess the phenotypic epidemiology and antimicrobial resistance profiles of bacteria isolated from clinically suspected neonatal sepsis in Ethiopia. Methods: A total of 342 neonates suspected of clinical sepsis were randomly included in a prospective observational study conducted at the neonatal intensive care unit (NICU) of Jimma medical center (JMC) from May 2022 to July 2023. Blood samples were collected from each neonate and subjected to a culture test for identification of bacterial isolates and their antibiotic resistance profiles following the standardized guidelines. The laboratory results, along with relevant clinical data, were recorded using WHONET and analyzed using STATA software. Results: Out of the 342 blood samples that were analyzed, 138 samples (40.4%, 95% CI: 35.1–45.6, P<0.01) exhibited proven bacterial infection. The infection rates were notably higher in males with 85/138 (61.6%, 95% CI: 53.4–69.8, P<0.01) and neonates aged 0–3 days with 81/138 (58.7%, 95% CI: 50.5–66.9, P<0.01). The majority of the infections were attributed to Gram-negative bacteria, accounting for 101/138(73.2%, 95% CI: 65.6–80.7) cases, with 69/101(68.3%, 95% CI: 63.8–72.8) cases involving ESBL-producing strains, while Gram-positive bacteria were responsible for 26.8% (95% CI: 19.3–34.4) of the infections. The predominant isolates included Klebsiella pneumoniae (37.7%, 95% CI: 29.6–45.8), Coagulase-negative Staphylococci (CoNs) (20.3%, 95% CI: 13.6–27.0), and Acinetobacter species (11.6%, 95% CI: 6.0–17.1). Of the total cases, 43/72 (59.7%, 95% CI: 48.4–71.1, P<0.01) resulted in mortality, with 28/72 (38.9%, 95% CI: 27.70–50.1, P<0.03) deaths linked to Extended-Spectrum Beta-Lactamase (ESBL)-producing strains. Klebsiella pneumoniae displayed high resistance rates to trimethoprim-sulfamethoxazole (100%), ceftriaxone (100%), cefotaxime (98.1%), ceftazidime (90.4%), and gentamicin (84.6%). Acinetobacter species showed resistance to ampicillin (100%), cefotaxime (100%), trimethoprim-sulfamethoxazole (75%), ceftazidime (68.8%), chloramphenicol (68.8%), and ceftriaxone (68.8%). Likewise, CoNs displayed resistance to ampicillin (100%), penicillin (100%), cefotaxime (86.0%), gentamicin (57.2%), and oxacillin (32.2%). Multidrug resistance was observed in 88.4% (95% CI: 81.8–93.0) of isolates, with ESBL-producers significantly contributing (49.3%, 95% CI: 45.1–53.5). Furthermore, 23.0% (95% CI: 15.8–31.6) exhibited a prevalent resistance pattern to seven distinct antibiotic classes. Conclusion: The prevalence and mortality rates of neonatal sepsis were significantly high at JMC, with a notable surge in antibiotic and multidrug resistance among bacterial strains isolated from infected neonates, specifically ESBL-producers. These resistant strains have a significant impact on infection rates and resistance profiles, highlighting the requisite for enhanced diagnostic and antimicrobial stewardship, stringent infection control, and further molecular characterization of isolates to enhance neonatal survival.

14 September 2016 in Journal of Pediatrics & Neonatal Care
Verified
Journal Article
Open access
PDF file
HEHaimanot Ewnetu
Haimanot Ewnetu
DGDaniel Geleta
Daniel Geleta
Background: Pneumonia is the leading cause of death in children under the age of 5 years. Ethiopia is ranked the fifth of 15 countries having the highest death rate of under five children due to pneumonia. Objective: To identify determinants of Community Acquired Pneumonia (CAP) among 2-59 months old children. Methods: Unmatched case control study was conducted in Kersa district, Southwest Ethiopia. A 95% confidence interval is desired with 90% statistical power and 1:1 ratio of controls to cases. Data were collected using structured and pre-tested questionnaire, entered into EpiData and analyzed using SPSS version 20. WHO Anthro plus was used to calculate nutrition indexes. Binary logistic regression analysis was used to test associations between the potential factors and the dependent variable. Variables with P-value < 0.25 during bivariate analysis were included to multivariate logistic regression model. Finally, variables with P-value < 0.05 were expressed as potential determinants of Community Acquired Pneumonia. Results: Maternal age (AOR= 5.3; 95% CI: 1.9, 14.3), previous upper respiratory tract infection (AOR= 5.2; 95% CI: 3.1, 8.9), current parental smoking (AOR= 1.9; 95% CI: 1.1, 3.7), more than four family members (AOR= 2.1; 95% CI: 1.1, 3.9), non-exclusive breast feeding during the first six month of life (AOR= 3.3; 95% CI: 2.0, 5.4), lack of zinc supplementation (AOR= 1.7; 95% CI: 1.1, 2.8) and wasting (AOR= 2.0; 95% CI: 1.2, 3.5) were determinants of Community Acquired Pneumonia among 2-59 months old children. Conclusion: Community Acquired Pneumonia is associated with young maternal age, large family size, parental smoking, non-exclusive breast feeding, lack of zinc supplementation, wasting and Previous Upper Respiratory Tract Infection. Therefore, improving child nutritional status, avoidance of smoking, limiting family size and early control of respiratory tract information could have significant salubrious effects on the event of Community Acquired pneumonia.

18 December 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DGDaniel Geleta
Daniel Geleta
GAGemeda Abebe
Gemeda Abebe
TTTsion Tilahun
Tsion Tilahun
AAAlemseged Abdissa
Alemseged Abdissa
AMAdane Mihret
Adane Mihret
GBGetenet Beyene
Getenet Beyene
Klebsiella bacterial strains harboring Extended-Spectrum Beta-Lactamase (ESBL) enzymes are the primary culprits behind neonatal sepsis globally. These strains significantly impact clinical outcomes due to their multi-drug resistance patterns in local healthcare settings. In response to this spiraling threat, we studied the prevalence and clinical implications of ESBL-encoding genes in neonates hospitalized with confirmed sepsis. A correlational study was conducted on 51 neonates diagnosed with sepsis caused by ESBL-positive Klebsiella pneumoniae at Jimma Medical Center spanning from May 2022 to July 2023. Antimicrobial resistance profiles of the bacterial isolates were determined using the Kirby-Bauer diffusion test, while multiplex polymerase chain reaction (mPCR) techniques were employed to identify resistance genes. The correlation between resistance genes and treatment outcomes was analyzed using the phi coefficient (φ) with a significance level below 0.05. The data management was executed through the utilization of WHONET and STATA software platforms. The sample consisted of 26 (50.9%) male and the remaining 25 (49.1%) female neonates, with diverse clinical characteristics. All 51 Klebsiella pneumoniae isolates were 100% resistant to trimethoprim/sulfamethoxazole and ceftriaxone, but showed varying resistance profiles ranging from 30.8% to meropenem to 94.2% to ceftazidime. Notably, all isolates demonstrated multidrug resistance, with 23% of cases showing resistance to seven different antimicrobial classes. The most prevalent resistance genes identified were blaCTX−M (96.1%), blaTEM (94.1%), and blaSHV (88.2%). The majority of isolates (94.1%) carried at least two resistance genes, such as blaTEM and blaCTX (94.1%), blaTEM and blaSHV (86.2%), and blaCTX and blaSHV (86.2%). Notably, 84.3% of the bacteria harbored the trio of blaTEM, blaCTX, and blaSHV resistance genes, and only the presence of blaSHV in monogenic (φ = 0.4, P = 0.01) or the trio of blaTEM, blaCTX, and blaSHV genes (φ = 0.3, P = 0.02) showed positive correlation with neonatal mortality. We observed a significant prevalence of multidrug-resistant Klebsiella pneumoniae strains among neonates. Moreover, ESBL-resistance genes were widespread, with the blaSHV gene showing a correlation with increased neonatal mortality. These findings emphasize the urgent need for enhanced infection prevention measures, robust antimicrobial resistance surveillance, innovative treatment strategies, antibiotic stewardship initiatives, further research into resistance transfer mechanisms as well as hierarchical predictors of neonatal mortality. Not applicable.

2 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DGDaniel Geleta
Daniel Geleta
GAGemeda Abebe
Gemeda Abebe
NWNetsanet Workneh
Netsanet Workneh
GBGetenet Beyene
Getenet Beyene
Background: Neonatal sepsis remains a leading cause of morbidity and mortality in neonates across all regions, including Africa. Compared to developed and some developing countries, there are relatively few epidemiological trends for neonatal sepsis and associated patterns with COVID-19 in Ethiopia. We modeled an epidemiological trend and pattern to aid in the monitoring of changes in neonatal sepsis. Methods: Retrospective data were collected from all admissions to the Neonatal Intensive Care Unit (NICU) in Ethiopia at Jimma Medical Center between May 2019 and April 2022. We analyzed the monthly neonatal sepsis incidence, mortality, and case-fatality rates using STATA software. Finally, we modeled a monthly time series of neonatal sepsis incidence trends and patterns associated with the COVID-19-impacted period using Joinpoint software. For all analyses, a P value of 0.05 was considered statistically significant at the 95% confidence interval (CI). Results: In the 36 months, 6796 cases were admitted to the NICU, with a 9.5% (95% CI: 9.1, 10.0) incidence rate of neonatal sepsis. The overall admission mortality rate was 16.5% (95% CI: 13.6, 19.8), while sepsis-attributed mortality was 7.1% (95% CI: 5.8, 8.5). The data showed an unstable decreasing trend for three Joinpoints (August 2020, December 2020, and August 2021). Notably, a decrease in the incidence trend was observed from May 2019 to August 2020 (MPC, -4.1; 95% CI: -7.6, -0.5; P = 0.03), followed by a sharp increase (MPC, 23.7; 95% CI: -13.8, 77.7; P = 0.24) from August 2020 to December 2020. From December 2020 to August 2021, there was again a decreasing trend (MPC, -13.8; 95% CI: -23.3, -3.5; P = 0.01), followed by a slight increase from August 2021 to April 2022 (MPC, 4.2; 95% CI: -8.4, 18.6; P = 0.52). Finally, the study revealed an association between patterns of neonatal sepsis incidence trends and COVID-19, with a Joinpoint jump model comparability ratio (CR = 0.43) between pre- and COVID-19-impacted periods. Conclusions: Neonatal sepsis was prevalent at Jimma Medical Center, but it was on an unstably declining trend. The current results suggest a potential temporal association between the intensity of COVID-19 containment measures and a change in the incidence trend and patterns of neonatal sepsis. However, the quantified contribution of a particular containment measure requires further investigation.

1 March 2024
Verified
Journal Article
Closed access
DGDaniel Geleta
Daniel Geleta
GAGemeda Abebe
Gemeda Abebe
BABikila Alemu
Bikila Alemu
NWNetsanet Workneh
Netsanet Workneh
GBGetenet Beyene
Getenet Beyene